Skip to main content
HCPCS J1096 · Level II · Part B drug

J1096: dexamethasone (Dextenza), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1096

Billing unit
0.1 MG
Dexametha opth insert 0.1 mg
ASP payment limit
$87.902
October 2026; -2.4% vs July 2026
Practitioner MUE
8
MAI 2
OPPS status
SI K1
APC 9308
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1096 is the Level II code for Dexamethasone, lacrimal ophthalmic insert, 0.1 mg, billed per 0.1 MG. The Medicare Part B ASP payment limit for October 2026 is $87.902 per billing unit, down 2.4% from July 2026. The practitioner MUE allows up to 8 units per date of service (MAI 2), so a full 8-unit day is $703.22 at the current limit. Under OPPS it carries status indicator K1 in APC 9308. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names dexamethasone: J7312 (Ozurdex from Allergan, Inc.; implant and intravitreal route); J8540 (the code whose CMS descriptor names no specific product; oral route; billed per 0.25 mg); J8541 (Hemady from Edenbridge Pharmaceuticals LLC.; oral route; billed per 0.25 mg). The ASP crosswalk maps 2 NDCs to it, sold as Dextenza by Ocular Therapeutix. No current Billing and Coding Article lists J1096, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1096 at $87.902 per 0.1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $90.019 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1096
QuarterPayment limitPerCoinsurance
October 2026$87.9020.1 MG20%
July 2026$90.0190.1 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 1 labeler to J1096. Report the NDC in the claim's drug segment and bill the number of J1096 units that equals the quantity administered divided by 0.1 MG; the last column gives units per full package.

NDCs that crosswalk to J1096
NDCDrug nameLabelerPackage sizeBilling units / package
70382-0204-01DextenzaOcular Therapeutix1 × 14
70382-0204-10DextenzaOcular Therapeutix1 × 1040

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for J1096. For practitioners the limit is 8 units per date of service with adjudication indicator 2, a date-of-service policy edit: the limit reflects CMS policy and units above it deny even if split across lines; appeals rarely succeed.

MUE values for J1096 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services82 Date of Service Edit: PolicyAnatomic Consideration
Facility outpatient hospital82 Date of Service Edit: PolicyAnatomic Consideration

MUE for J1096 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1096 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1096 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1096 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1096 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1096 carries status indicator K1 and is assigned to APC 9308, with a published national unadjusted payment of $87.902. The OPPS status indicator reference explains how status K1 is paid.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1096 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $87.90 per 0.1 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J1096 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1096

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1096

What does HCPCS code J1096 describe?

J1096 is defined by CMS as "Dexamethasone, lacrimal ophthalmic insert, 0.1 mg". Each billing unit represents 0.1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1096 a CPT code?

No. J1096 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as dexamethasone (Dextenza); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1096 reports the drug itself in 0.1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1096 in October 2026?

The ASP-based payment limit is $87.902 per 0.1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $90.019. Commercial payers use their own fee schedules.

How many units of J1096 can be billed per day?

The practitioner Medically Unlikely Edit is 8 units per date of service with adjudication indicator 2 (Date of Service Edit: Policy). MAI 2 edits are policy limits and are rarely overturned on appeal. CMS cites "Anatomic Consideration" as the rationale.

Which NDCs map to J1096?

The October 2026 ASP crosswalk lists 2 NDCs from 1 labeler: Dextenza (Ocular Therapeutix). For example NDC 70382-0204-01 (package size 1) equals 4 billing units of J1096.

Does J1096 have NCCI bundling edits?

No active practitioner PTP pairs list J1096 as a column-1 or column-2 code in the v323r0 release.

J1096 vs J7312: what is the difference?

Both are HCPCS Level II codes whose descriptor names dexamethasone. What sets J7312 apart: Ozurdex from Allergan, Inc.; implant and intravitreal route. J1096 is billed per 0.1 mg, limit $87.902, MUE 8; J7312 is billed per 0.1 mg, limit $202.424, MUE 14. Report the code whose descriptor matches the product and setting in the record.

J1096 vs J8540: what is the difference?

Both are HCPCS Level II codes whose descriptor names dexamethasone. What sets J8540 apart: the code whose CMS descriptor names no specific product; oral route; billed per 0.25 mg. J1096 is billed per 0.1 mg, limit $87.902, MUE 8; J8540 is billed per 0.25 mg, limit $0.022, MUE 0. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.